REIT - Retail
Compare Stocks
5 / 10Stock Comparison
CBL vs WELL vs SPG vs VTR vs MAC
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
REIT - Retail
REIT - Healthcare Facilities
REIT - Retail
CBL vs WELL vs SPG vs VTR vs MAC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | REIT - Retail | REIT - Healthcare Facilities | REIT - Retail | REIT - Healthcare Facilities | REIT - Retail |
| Market Cap | $1.36B | $149.25B | $65.50B | $41.15B | $5.56B |
| Revenue (TTM) | $578M | $11.63B | $6.36B | $6.13B | $1.01B |
| Net Income (TTM) | $136M | $1.43B | $4.61B | $260M | $-183M |
| Gross Margin | 7.6% | 39.1% | 85.7% | -4.3% | 47.9% |
| Operating Margin | 24.2% | 4.4% | 49.9% | 13.4% | 29.2% |
| Forward P/E | 47.7x | 78.4x | 30.3x | 118.0x | — |
| Total Debt | $2.17B | $21.38B | $29.94B | $13.22B | $5.20B |
| Cash & Equiv. | $42M | $5.03B | $823M | $741M | $43M |
CBL vs WELL vs SPG vs VTR vs MAC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Nov 21 | May 26 | Return |
|---|---|---|---|
| CBL & Associates Pr… (CBL) | 100 | 141.8 | +41.8% |
| Welltower Inc. (WELL) | 100 | 267.5 | +167.5% |
| Simon Property Grou… (SPG) | 100 | 131.8 | +31.8% |
| Ventas, Inc. (VTR) | 100 | 184.4 | +84.4% |
| The Macerich Company (MAC) | 100 | 113.3 | +13.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CBL vs WELL vs SPG vs VTR vs MAC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CBL is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 1 yrs, beta 0.68, yield 5.7%
- Beta 0.68, yield 5.7%, current ratio 2.55x
- 5.7% yield, 1-year raise streak, vs WELL's 1.3%, (1 stock pays no dividend)
- +88.2% vs SPG's +30.1%
WELL ranks third and is worth considering specifically for long-term compounding and sleep-well-at-night.
- 223.1% 10Y total return vs CBL's 78.3%
- Lower volatility, beta 0.13, Low D/E 49.5%, current ratio 5.34x
- 35.8% FFO/revenue growth vs SPG's 6.7%
SPG carries the broadest edge in this set and is the clearest fit for value and quality.
- Lower P/E (30.3x vs 118.0x)
- 72.5% margin vs MAC's -18.2%
- 11.4% ROA vs MAC's -2.7%, ROIC 7.6% vs 1.6%
VTR is the clearest fit if your priority is growth exposure.
- Rev growth 18.5%, EPS growth 184.2%, 3Y rev CAGR 12.2%
- Beta 0.01 vs MAC's 1.29, lower leverage
Among these 5 stocks, MAC doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 35.8% FFO/revenue growth vs SPG's 6.7% | |
| Value | Lower P/E (30.3x vs 118.0x) | |
| Quality / Margins | 72.5% margin vs MAC's -18.2% | |
| Stability / Safety | Beta 0.01 vs MAC's 1.29, lower leverage | |
| Dividends | 5.7% yield, 1-year raise streak, vs WELL's 1.3%, (1 stock pays no dividend) | |
| Momentum (1Y) | +88.2% vs SPG's +30.1% | |
| Efficiency (ROA) | 11.4% ROA vs MAC's -2.7%, ROIC 7.6% vs 1.6% |
CBL vs WELL vs SPG vs VTR vs MAC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CBL vs WELL vs SPG vs VTR vs MAC — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
SPG leads in 2 of 6 categories
MAC leads 1 • WELL leads 1 • VTR leads 1 • CBL leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
SPG leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
WELL is the larger business by revenue, generating $11.6B annually — 20.1x CBL's $578M. SPG is the more profitable business, keeping 72.5% of every revenue dollar as net income compared to MAC's -18.2%. On growth, WELL holds the edge at +40.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $578M | $11.6B | $6.4B | $6.1B | $1.0B |
| EBITDAEarnings before interest/tax | $305M | $2.8B | $4.7B | $2.3B | $648M |
| Net IncomeAfter-tax profit | $136M | $1.4B | $4.6B | $260M | -$183M |
| Free Cash FlowCash after capex | $255M | $2.5B | $2.3B | $1.4B | $337M |
| Gross MarginGross profit ÷ Revenue | +7.6% | +39.1% | +85.7% | -4.3% | +47.9% |
| Operating MarginEBIT ÷ Revenue | +24.2% | +4.4% | +49.9% | +13.4% | +29.2% |
| Net MarginNet income ÷ Revenue | +23.5% | +12.3% | +72.5% | +4.2% | -18.2% |
| FCF MarginFCF ÷ Revenue | +44.1% | +21.9% | +35.4% | +22.4% | +33.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +18.8% | +40.3% | +13.2% | +22.0% | -3.1% |
| EPS Growth (YoY)Latest quarter vs prior year | +27.9% | +22.5% | +3.6% | 0.0% | +30.0% |
Valuation Metrics
MAC leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 10.1x trailing earnings, CBL trades at a 94% valuation discount to VTR's 160.3x P/E. On an enterprise value basis, CBL's 11.4x EV/EBITDA is more attractive than WELL's 66.4x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $1.4B | $149.2B | $65.5B | $41.1B | $5.6B |
| Enterprise ValueMkt cap + debt − cash | $3.5B | $165.6B | $94.6B | $53.6B | $10.7B |
| Trailing P/EPrice ÷ TTM EPS | 10.12x | 153.25x | 14.24x | 160.26x | -27.75x |
| Forward P/EPrice ÷ next-FY EPS est. | 47.74x | 78.42x | 30.29x | 118.01x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | 0.45x | — | — |
| EV / EBITDAEnterprise value multiple | 11.44x | 66.40x | 20.31x | 24.31x | 20.10x |
| Price / SalesMarket cap ÷ Revenue | 2.35x | 13.99x | 10.29x | 7.05x | 5.48x |
| Price / BookPrice ÷ Book value/share | 3.71x | 3.35x | 9.79x | 3.18x | 2.17x |
| Price / FCFMarket cap ÷ FCF | 18.93x | 52.41x | — | 31.25x | 17.29x |
Profitability & Efficiency
SPG leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
SPG delivers a 68.8% return on equity — every $100 of shareholder capital generates $69 in annual profit, vs $-7 for MAC. WELL carries lower financial leverage with a 0.49x debt-to-equity ratio, signaling a more conservative balance sheet compared to CBL's 5.95x. On the Piotroski fundamental quality scale (0–9), CBL scores 7/9 vs MAC's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +42.9% | +3.5% | +68.8% | +2.1% | -7.1% |
| ROA (TTM)Return on assets | +5.1% | +2.3% | +11.4% | +1.0% | -2.7% |
| ROICReturn on invested capital | +4.2% | +0.5% | +7.6% | +2.5% | +1.6% |
| ROCEReturn on capital employed | +5.5% | +0.6% | +9.1% | +3.2% | +2.2% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 7 | 5 | 6 | 4 |
| Debt / EquityFinancial leverage | 5.95x | 0.49x | 4.47x | 1.05x | 2.06x |
| Net DebtTotal debt minus cash | $2.1B | $16.3B | $29.1B | $12.5B | $5.2B |
| Cash & Equiv.Liquid assets | $42M | $5.0B | $823M | $741M | $43M |
| Total DebtShort + long-term debt | $2.2B | $21.4B | $29.9B | $13.2B | $5.2B |
| Interest CoverageEBIT ÷ Interest expense | 1.77x | 0.26x | 3.26x | 1.40x | 0.18x |
Total Returns (Dividends Reinvested)
WELL leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WELL five years ago would be worth $30,234 today (with dividends reinvested), compared to $17,479 for VTR. Over the past 12 months, CBL leads with a +88.2% total return vs SPG's +30.1%. The 3-year compound annual growth rate (CAGR) favors WELL at 42.5% vs VTR's 24.8% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +20.6% | +14.3% | +10.7% | +12.6% | +16.3% |
| 1-Year ReturnPast 12 months | +88.2% | +42.7% | +30.1% | +33.9% | +48.2% |
| 3-Year ReturnCumulative with dividends | +123.4% | +189.5% | +109.2% | +94.2% | +137.2% |
| 5-Year ReturnCumulative with dividends | +78.3% | +202.3% | +91.4% | +74.8% | +78.3% |
| 10-Year ReturnCumulative with dividends | +78.3% | +223.1% | +28.9% | +65.0% | -55.2% |
| CAGR (3Y)Annualised 3-year return | +30.7% | +42.5% | +27.9% | +24.8% | +33.4% |
Risk & Volatility
VTR leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
VTR is the less volatile stock with a 0.01 beta — it tends to amplify market swings less than MAC's 1.29 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. VTR currently trades 97.8% from its 52-week high vs MAC's 94.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.68x | 0.13x | 0.61x | 0.01x | 1.29x |
| 52-Week HighHighest price in past year | $45.86 | $219.59 | $208.28 | $88.50 | $22.55 |
| 52-Week LowLowest price in past year | $23.92 | $142.65 | $155.44 | $61.76 | $14.82 |
| % of 52W HighCurrent price vs 52-week peak | +95.8% | +97.0% | +96.7% | +97.8% | +94.7% |
| RSI (14)Momentum oscillator 0–100 | 60.9 | 60.2 | 61.2 | 56.2 | 66.3 |
| Avg Volume (50D)Average daily shares traded | 171K | 2.6M | 1.4M | 3.4M | 2.0M |
Analyst Outlook
Evenly matched — CBL and WELL and SPG each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CBL as "Hold", WELL as "Buy", SPG as "Hold", VTR as "Buy", MAC as "Hold". Consensus price targets imply 6.3% upside for WELL (target: $227) vs -2.2% for SPG (target: $197). For income investors, CBL offers the higher dividend yield at 5.69% vs WELL's 1.30%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Hold | Buy | Hold |
| Price TargetConsensus 12-month target | — | $226.50 | $197.00 | $90.80 | $21.40 |
| # AnalystsCovering analysts | 22 | 34 | 37 | 32 | 34 |
| Dividend YieldAnnual dividend ÷ price | +5.7% | +1.3% | — | +2.1% | +3.2% |
| Dividend StreakConsecutive years of raises | 1 | 2 | 2 | 1 | 1 |
| Dividend / ShareAnnual DPS | $2.50 | $2.76 | — | $1.86 | $0.68 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.3% | 0.0% | 0.0% | 0.0% | 0.0% |
SPG leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). MAC leads in 1 (Valuation Metrics). 1 tied.
CBL vs WELL vs SPG vs VTR vs MAC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CBL or WELL or SPG or VTR or MAC a better buy right now?
For growth investors, Welltower Inc.
(WELL) is the stronger pick with 35. 8% revenue growth year-over-year, versus 6. 7% for Simon Property Group, Inc. (SPG). CBL & Associates Properties, Inc. (CBL) offers the better valuation at 10. 1x trailing P/E (47. 7x forward), making it the more compelling value choice. Analysts rate Welltower Inc. (WELL) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CBL or WELL or SPG or VTR or MAC?
On trailing P/E, CBL & Associates Properties, Inc.
(CBL) is the cheapest at 10. 1x versus Ventas, Inc. at 160. 3x. On forward P/E, Simon Property Group, Inc. is actually cheaper at 30. 3x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — CBL or WELL or SPG or VTR or MAC?
Over the past 5 years, Welltower Inc.
(WELL) delivered a total return of +202. 3%, compared to +74. 8% for Ventas, Inc. (VTR). Over 10 years, the gap is even starker: WELL returned +223. 1% versus MAC's -55. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CBL or WELL or SPG or VTR or MAC?
By beta (market sensitivity over 5 years), Ventas, Inc.
(VTR) is the lower-risk stock at 0. 01β versus The Macerich Company's 1. 29β — meaning MAC is approximately 13512% more volatile than VTR relative to the S&P 500. On balance sheet safety, Welltower Inc. (WELL) carries a lower debt/equity ratio of 49% versus 6% for CBL & Associates Properties, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CBL or WELL or SPG or VTR or MAC?
By revenue growth (latest reported year), Welltower Inc.
(WELL) is pulling ahead at 35. 8% versus 6. 7% for Simon Property Group, Inc. (SPG). On earnings-per-share growth, the picture is similar: Ventas, Inc. grew EPS 184. 2% year-over-year, compared to -11. 5% for Welltower Inc.. Over a 3-year CAGR, WELL leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CBL or WELL or SPG or VTR or MAC?
Simon Property Group, Inc.
(SPG) is the more profitable company, earning 72. 5% net margin versus -19. 4% for The Macerich Company — meaning it keeps 72. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SPG leads at 49. 9% versus 3. 3% for WELL. At the gross margin level — before operating expenses — SPG leads at 85. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CBL or WELL or SPG or VTR or MAC more undervalued right now?
On forward earnings alone, Simon Property Group, Inc.
(SPG) trades at 30. 3x forward P/E versus 118. 0x for Ventas, Inc. — 87. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for WELL: 6. 3% to $226. 50.
08Which pays a better dividend — CBL or WELL or SPG or VTR or MAC?
In this comparison, CBL (5.
7% yield), MAC (3. 2% yield), VTR (2. 1% yield), WELL (1. 3% yield) pay a dividend. SPG does not pay a meaningful dividend and should not be held primarily for income.
09Is CBL or WELL or SPG or VTR or MAC better for a retirement portfolio?
For long-horizon retirement investors, Ventas, Inc.
(VTR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 01), 2. 1% yield). Both have compounded well over 10 years (VTR: +65. 0%, MAC: -55. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CBL and WELL and SPG and VTR and MAC?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CBL is a small-cap deep-value stock; WELL is a mid-cap high-growth stock; SPG is a mid-cap deep-value stock; VTR is a mid-cap high-growth stock; MAC is a small-cap income-oriented stock. CBL, WELL, VTR, MAC pay a dividend while SPG does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.